2004 Fiscal Year Final Research Report Summary
Molecular mechanisms of ischemia/reperfusion-induced renal injury
Project/Area Number |
14570092
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
General pharmacology
|
Research Institution | Osaka University of Pharmaceutical Sciences |
Principal Investigator |
MATSUMURA Yasuo Osoka University of Phamaceutical Siences, Pharmacology, Professor, 薬学部, 教授 (40140230)
|
Co-Investigator(Kenkyū-buntansha) |
TAKAOKA Masanori Osaka University of Pharmaceutical Sciences, Phannacology, Associate Professor, 薬学部, 助教授 (50140231)
|
Project Period (FY) |
2002 – 2004
|
Keywords | kidney / ischemia / acute renal failure / Na^+ / Ca^<2+> exchanger / nitric oxide / peroxynitrite / Rho-kinase / endothelin-1 |
Research Abstract |
(1) : To investigate the role of Rho-kinase in the pathogenesis of ischemic acute renal failure (ARF), we examined the effect of Y-27632, a selective Rho-kinase inhibitor, on the ischemia/reperfusion-induced ARF. Y-27632 markedly suppressed the development of ischemia/reperfusion (I/R)-induced ARF and the effects was related to the suppression of neutrophil infiltration, thereby suggesting that the Rho/Rho-kinase pathway plays a key role in the pathogenesis of ischemic ARE. (2) : We evaluated the effects of SEA0400, a novel and selective Na^+/Ca^<2+> exchange (NCX) inhibitor, on ischemic ARF SEA0400 dose-dependently attenuated the I/R-induced renal dysfunction and histological damage. Next, using NCX^<+/-> heterozygous mice, the pathophysiological role of Ca^<2+> overload via the reverse mode of NCX in I/R-induced renal injury, was investigated. I/R-induced renal dysfunction in heterozygous mice were significantly attenuated compared with cases in wild-type mice. Histological renal dama
… More
ge in heterozygous mice was much less than that in wild-type mice. Increases in renal endothelin-1 content were greater in wild-type than in heterozygous mice. These findings strongly support the view that Ca^<2+> overload via the reverse-mode of NCX, followed by renal endothelin-1 overproduction, plays an important role in the pathogenesis of I/R-induced renal injury. In addition, the possibility exists that a selective NCX inhibitor such as SEA0400 is useful as effective therapeutic agent against ischemic ARF. (3): Effects of nitric oxide (NO) donor, FK409, on the I/R-induced ARE were investigated. The pre-ischemic treatment with FK409 markedly suppressed the renal lesion by the antioxidative action and decreasing endothelin-1 production. In contrast, the post-ischemic treatment with FK409 aggravated the I/R-induced renal dysfunction and histological damage. Immunohistochemical analysis of renal sections obtained from ARE rats revealed positive staining for nitrotyrosine, a biomarker of peroxynitrite formation, in injured tubular cells, and more intense staining was observed in renal tissues from animals received post-ischemic treatment with FK409. These results demonstrate that, although pre-ischemic treatment with NO donor is renoprotective, post-ischemic treatment with the same agent aggravates the I/R-induced renal injury, probably through the peroxynitrite overproduction. Less
|
Research Products
(17 results)